Access VetMed’s 21st General Assembly, held on 8th September 2023 in Utrecht, The Netherlands, elected Xavier Molins as its new Chair, for the next term 2023 – 2026. Xavier has almost 30 years of experience in the pharmaceutical Industry, with over 20 years in the Animal Health sector where he held Senior positions in both R&D and Regulatory Affairs. Currently, Xavier is the Head of Regulatory Affairs in Europe at Bimeda Animal Health Limited.

The event was attended by over 60 delegates from the Access VetMed membership, which has 27 member companies from several EU countries.


“I look forward to representing the interests of the European generic and added value veterinary medicines industry in these challenging times of considerable effort to adapt to the new regulatory landscape, and of geopolitical factors which impact the economic sustainability of the pharmaceutical supply value chain”, said Xavier. “Our industry can offer added value medicines with improved features to support animal treatment, welfare and care, such as products with a more convenient form of administration, dosage or palatability; this also brings more access to treatments. As Access VetMed Chair, I will do my utmost to promote increase access to veterinary medicines for the veterinarians, and farm and companion animals in Europe, as well as to work actively and constructively with the EU regulators and other stakeholders for transparent, harmonised, pragmatic and balanced animal health regulation.”

The 21st General Assembly also elected a new Access VetMed Board:


Leo Aerden




Slavka Pavlič




Xavier Molins




Dolores Cainzos

Vice Chair

Lab. Maymó


Andreas Asamer

Board Member

VetViva Richter